- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07237490
Effectiveness of Modified Constraint-Induced Movement Therapy Delivered Via Telerehabilitation in Children With Unilateral Cerebral Palsy: A Prospective Randomized Controlled Trial
In Our Prospective and Randomized Controlled Study, 42 Children With Unilateral Cerebral Palsy Were Included and Randomized as the mCIMT Group Delivered Via Telerehabilitation (n=21) and the Control Group (n=21). The First Group Received mCIMT Treatment Together With Telerehabilitation for 1 Hour, 3 Times a Week for 6 Weeks. In Addition, 30 Minutes of Indoor Activity Practices Were Performed Every Day. The Second Group Received a Home Program Under the Supervision of Parents for 1 Hour, 3 Times a Week for 6 Weeks.
Aim:In this prospective and randomized controlled thesis study; we aimed to compare Modified Constraint-Induced Movement Therapy (mCIMT) delivered via Telerehabilitation with the home program in children with Unilateral Cerebral Palsy (CP) and to determine whether Telerehabilitation has a positive effect on upper extremity functions and quality of life.
Method: In our prospective and randomized controlled study, 42 children with unilateral cerebral palsy were included and randomized as the mCIMT group delivered via Telerehabilitation (n=21) and the control group (n=21).
The first group received mCIMT treatment together with Telerehabilitation for 1 hour, 3 times a week for 6 weeks. In addition, 30 minutes of indoor activity practices were performed every day.
The second group received a home program under the supervision of parents for 1 hour, 3 times a week for 6 weeks.
.In the randomized double-blind study, initial assessments, post-treatment and follow-up assessments were performed by the researcher who was blinded to the group distribution.
The primary outcome measure was the Assisting Hand Assessment (AHA), which was used to evaluate upper extremity function. The researcher administering this assessment was blinded to group allocation. Secondary outcome measures included the Modified Jebsen Taylor Hand Function Test, range of motion assessed with a goniometer, spasticity evaluated using the Modified Ashworth Scale, grip strength measured with a Jamar dynamometer, manual ability classified using the Manual Ability Classification System (MACS), activities of daily living assessed by ABILHAND-Kids, and quality of life evaluated using the KINDL questionnaire.
Post-treatment assessments were performed at the beginning of the study and 6 weeks after treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Fatih
-
Istanbul, Fatih, Turkey (Türkiye)
- Istanbul University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Inclusion between the ages of 4-12
- Diagnosis of unilateral CP by a specialist
- Ability to extend the suspected wrist more than 10°
- Demonstration of ability to follow simple commands and participation in assigned tasks
- Gross Motor Function Classification System Level 1 or 2
- Manual Skills Classification System Level 1, 2 or 3
- Muscle tone is normal/mild/moderate (Modified Ashworth Scale level 0-1-2)
- No contractures in the upper extremity
- Agrees to attend intensive therapy sessions and to stop all other upper extremity therapeutic interventions for the 3-month follow-up period
Exclusion Criteria:
- Significant contractures in the wrist, elbow, and fingers that prevent daily activities
- Lack of active movement in the affected upper extremity
- Cognitive impairment that causes inability to understand and perform simple commands and tasks
- Inability to continue treatment protocol due to school schedule
- Uncontrolled disease (endocrinologic, cardiovascular, pulmonary, hematologic, hepatic, renal), active systemic inflammatory disease, and/or history of malignancy
- Current or previous treatments not compatible with the study treatment protocol
- Orthopedic surgery (tendon transfer/tendon lengthening) performed on the affected upper extremity
- Botulinum toxin injection into upper extremity muscles within the last 6 months
- Dorsal rhizotomy
- Intrathecal baclofen pump
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: via Telerehabilitation mCIMT
The first group received mCIMT treatment together with Telerehabilitation for 1 hour, 3 times a week for 6 weeks. In addition, 30 minutes of indoor activity practices were performed every day. The second group received a home program under the supervision of parents for 1 hour, 3 times a week for 6 weeks. |
In this group, patients aged 4-12 with unilateral cerebral palsy received mCIMT via the Eczacıbaşı EVITAL app for upper extremity rehabilitation.
For six weeks, they performed mCIMT three times a week for one hour under therapist supervision and with parental supervision, two times a week for one hour under parental supervision, and half an hour each day of selected daily activities using the affected extremity, with gloves on the unaffected extremity.
|
|
Active Comparator: home exercises control group
A 1-hour home program will be implemented 3 days a week.
|
Patients in this group with unilateral CP underwent a home exercise program, which they continued for one hour, three days a week. The upper extremity exercise program included range of motion exercises, stretching exercises, activities of daily living exercises, and play-based exercises. This program lasted an average of 60 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assisting Hand Assessment
Time Frame: before treatment and 6 weeks after treatment
|
The AHA is a test that measures how patients with upper extremity dysfunction, such as hemiplegic CP or congenital brachial plexus injury, use their affected hand in conjunction with their unaffected hand during two-handed play.
It was first validated in children aged 18 months to 5 years (Small Kids AHA), and then two play tables were created for children aged 6 to 12 years (School Kids AHA).
In this assessment method, a camera records the child performing tasks and playing with both hands.
This assessment method can be administered by healthcare professionals who have completed the training and received certification.
The test consists of two stages: first, the assessor (therapist, physician) sits opposite the child, and an environment is prepared using age-appropriate toys from the AHA kit to enable the child to perform all upper extremity functions using both hands.
A camera positioned behind the assessor records this process.
|
before treatment and 6 weeks after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ABILHAND KIDS
Time Frame: before treatment and 6 weeks after treatment
|
ABILHAND-Kids is a scale that assesses the extent to which children with cerebral palsy can use their manual skills in daily living activities such as self-care, and the difficulties perceived by parents during these activities.
|
before treatment and 6 weeks after treatment
|
|
Modified Jebsen-Taylor Hand Function Test
Time Frame: before treatment and 6 weeks after treatment
|
The Jebsen-Taylor Hand Function Test (JFTT) is a standardized performance test developed to assess unimanual daily skills.
In this test, children are asked to perform tasks such as grasping, releasing, and moving objects at varying levels of difficulty as quickly and accurately as possible.
The assessment time is recorded in seconds.
|
before treatment and 6 weeks after treatment
|
|
Joint Range of Motion
Time Frame: before treatment and 6 weeks after treatment
|
In our study, ROM in the affected extremity was measured separately using a joint goniometer, both actively and passively, for finger flexion/extension, wrist flexion/extension, supination/pronation, elbow flexion/extension, and shoulder flexion/extension/abduction/adduction/internal rotation/external rotation.
|
before treatment and 6 weeks after treatment
|
|
Grip Strength
Time Frame: before treatment and 6 weeks after treatment
|
Grip strength was measured separately in both upper extremities using a Baseline® Smedley spring dynamometer (child, 110 lb, USA). The standard procedure outlined by Mathiowetz et al. was followed during the assessment: three maximum voluntary grips were performed for each hand. The average of these three measurements was taken, and the results were recorded in kilograms of force (kgF). |
before treatment and 6 weeks after treatment
|
|
Modified Ashworth Scale
Time Frame: before treatment and 6 weeks after treatment
|
Muscle tone was assessed in five major muscle groups in the affected upper extremity. The Modified Ashworth Scale (MAS) was used, and muscle tone was graded from 0 (normal) to 4 (significantly increased). The muscle groups assessed were: elbow flexors, elbow extensors, wrist flexors, wrist extensors, and finger flexors. |
before treatment and 6 weeks after treatment
|
|
KINDL
Time Frame: before treatment and 6 weeks after treatment
|
The Children's General Health-Related Quality of Life Scale (KINDL-R) is a self-report scale developed to assess the health-related quality of life of children and adolescents.
It is available in three versions to suit different age groups: the Kiddy-KINDL-R (interviewer-administered version) for children aged 4-7, the Kid-KINDL-R for children aged 8-12, and the Kiddo-KINDL-R for adolescents aged 13-16.
In addition, two parent forms are available that allow families to indirectly assess the quality of life of younger children (ages 4-7) and older children and adolescents (ages 8-16).
|
before treatment and 6 weeks after treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ayşe R AYDIN, Professor Doctor, Istanbul University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2480576
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on mCIMT Effect Via Telerehabilitation
-
Istanbul Medipol University HospitalCompletedExercise | Drug Effect | Telerehabilitation | Pelvic Floor | Dysmenorrhea Primary | AcupressureTurkey
Clinical Trials on mCIMT via Telerehabilitation
-
Istanbul UniversityCompletedScleroderma, Systemic | Rehabilitation | Physiotherapy | Scleroderma | Hand Rheumatism | Scleroderma Associated Digital UlcerTurkey
-
Izmir Bakircay UniversityCompleted
-
Instituto Mexicano del Seguro SocialCompleted
-
NODEHealth FoundationCompletedMyocardial Infarction | Myocardial Ischemia | Heart Diseases | Coronary Artery Disease | Angina, Stable | Angina Pectoris | Valve Disease, Heart | Coronary Artery Stenosis | Valve Heart DiseaseUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedDistal Radius FractureTurkey
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Scleroderma | Hand Rheumatism | Scleroderma Associated Digital UlcerTurkey
-
Fundacion Universitaria Maria CanoUniversidad Iberoamericana A.C., MexicoCompletedMultiple ComorbidityColombia
-
All India Institute of Medical Sciences, New DelhiUnknown
-
King Saud UniversityKing Fahad Medical City; King Saud Medical CityRecruitingStroke | Hemiparesis of the Upper Limb Following Stroke | Stroke RehabilitatiomSaudi Arabia
-
Universita di VeronaRecruitingMultiple Sclerosis | Telerehabilitation | Neurorehabilitation | Cognitive DisordersItaly